Furthermore, blood pressure control in hypertensive individuals, preferably with an angiotensin converting enzyme inhibitor or an angiotensin II1 receptor antagonist at a maximally tolerable dose, can reduce micro- and macro-albuminuria, prevent the progression of diabetic kidney disease and reduce mortality [87]. Here, ACE is linked to diabetic kidney disease.